$11.93
7.96%
Nasdaq, Aug 22, 10:00 pm CET

Tandem Diabetes Care, Inc. Stock price

$11.93
-3.38 22.08% 1M
-20.73 63.47% 6M
-24.09 66.88% YTD
-30.56 71.92% 1Y
-35.27 74.72% 3Y
-95.37 88.88% 5Y
-102.47 89.57% 10Y
-180.67 93.81% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.88 7.96%

Key metrics

Basic
Market capitalization
$806.1m
Enterprise Value
$799.9m
Net debt
positive
Cash
$315.4m
Shares outstanding
67.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.8 | 0.8
EV/Sales
0.8 | 0.8
EV/FCF
negative
P/B
6.1
Financial Health
Equity Ratio
27.2%
Return on Equity
-36.5%
ROCE
-14.9%
ROIC
-24.0%
Debt/Equity
2.3
Financials (TTM | estimate)
Revenue
$1.0b | $1.0b
EBITDA
$-75.9m | $32.5m
EBIT
$-93.0m | $-104.0m
Net Income
$-205.5m | $-144.0m
Free Cash Flow
$-54.2m
Growth (TTM | estimate)
Revenue
25.9% | 8.3%
EBITDA
38.2% | 139.4%
EBIT
33.1% | -5.0%
Net Income
-50.5% | -50.0%
Free Cash Flow
15.8%
Margin (TTM | estimate)
Gross
52.6%
EBITDA
-7.6% | 3.2%
EBIT
-9.3%
Net
-20.5% | -14.2%
Free Cash Flow
-5.4%
More
EPS
$-3.1
FCF per Share
$-0.8
Short interest
18.0%
Employees
3k
Rev per Employee
$350.0k
Show more

Is Tandem Diabetes Care, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Tandem Diabetes Care, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

16x Buy
53%
12x Hold
40%
2x Sell
7%

Analyst Opinions

30 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

Buy
53%
Hold
40%
Sell
7%

Financial data from Tandem Diabetes Care, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,002 1,002
26% 26%
100%
- Direct Costs 475 475
17% 17%
47%
526 526
35% 35%
53%
- Selling and Administrative Expenses 420 420
20% 20%
42%
- Research and Development Expense 199 199
11% 11%
20%
-76 -76
38% 38%
-8%
- Depreciation and Amortization 17 17
6% 6%
2%
EBIT (Operating Income) EBIT -93 -93
33% 33%
-9%
Net Profit -205 -205
50% 50%
-21%

In millions USD.

Don't miss a Thing! We will send you all news about Tandem Diabetes Care, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tandem Diabetes Care, Inc. Stock News

Neutral
Business Wire
11 days ago
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TANDEM DIABETES CARE, IN...
Neutral
Business Wire
11 days ago
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN TANDEM DIABETES CARE, INC. (TNDM), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY...
Neutral
Business Wire
11 days ago
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TANDEM DIABETES CARE, INC. (TNDM), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RE...
More Tandem Diabetes Care, Inc. News

Company Profile

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Head office United States
CEO John Sheridan
Employees 2,650
Founded 2006
Website www.tandemdiabetes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today